Reaction
Lung Adenocarcinoma Recurrent reporting signals
As of the last recalculation, Lung Adenocarcinoma Recurrent appears in 93 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is PEMETREXED (PRR 157.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pemetrexed | 13 | 157.6 | 157.7 |
| Pemetrexed Disodium | 17 | 122.0 | 122.0 |
| Durvalumab | 7 | 83.2 | 83.2 |